MedicinePharmacologyPharmacotherapyClinical PharmacologyEndocrine PharmacotherapyDiabetes ControlDiabetes ManagementDiabetes MellitusDiabetes PharmacotherapyGlycemic ControlHypoglycemia ManagementBeta-adrenergic AgentsBeta-adrenergic Blocker UseBeta-blocker UseGlucose-stimulated Insulin SecretionInsulin Secretion EnhancementPancreatic InsulinomaPropranolol Therapy
An insulinoma was diagnosed in a fifty-seven-year-old woman suffering from frequent hypoglycemic attacks. Propranolol--a beta-adrenergic blocker--in a dose of 80 mg. per day effectively prevented recurrent hypoglycemic attacks. It also corrected the basal hyperinsulinemia as well as the increased insulin secretion which results from stimulation with glucose or arginine.